Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

AI-ENDO assistance for endoscopic submucosal dissection (ESD)

Official title: Clinical Utility and Validation of Novel AI-ENDO System in Endoscopic Submucosal Dissection

Run by Chinese University of Hong Kong · NCT07392268 · Data updated 2026-11-12

This pilot will try using the AI-ENDO system to help doctors perform ESD in adults with superficial esophageal, stomach, or colorectal lesions.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedMay 1, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedFebruary 6, 2026
Trial IDNCT07392268 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 scheduled for conventional ESD for superficial esophageal, gastric, or colorectal lesions who can provide informed consent are the intended participants.

Probably not a fit

Patients with lesions unsuitable for ESD, those requiring alternative or more advanced cancer treatment, or people who decline participation are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial tests the AI-ENDO software during ESD procedures on adults with superficial lesions of the esophagus, stomach, or colon. In the first phase the system will run in the background for 30 conventional ESD cases to analyse real-time video without affecting the endoscopist and to provide a control dataset. A subsequent phase will use AI-ENDO to provide active, real-time support to endoscopists and compare technical and safety outcomes versus the background cases. All procedures are performed at the Endoscopy Centre of Prince of Wales Hospital under the Chinese University of Hong Kong.

Why it matters

Potential benefit: If successful, AI-ENDO could improve completeness and safety of ESD by offering real-time guidance that may reduce procedure time and complications.

How similar studies have gone: AI tools have shown promise for lesion detection and characterization in endoscopy, but AI-assisted guidance specifically for ESD is still early and has limited clinical validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient with superficial esophageal, gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD).
* Age between 18 and 85.

Exclusion Criteria:

* Patient who refused to participate.
* Other cases deemed by the examining physician as unsuitable for safe treatment.

Where it's running

  • Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.